Non‐self‐discrimination as a driving concept in the identification of an immunodominant HMW‐MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients
Open Access
- 20 May 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 111 (5) , 720-726
Abstract
We analyzed the sera of patients with melanoma to define the human humoral autoantibody profile towards HMW‐MAA. Computational proteome scanning using the non‐self‐discrimination principle as a guide led to the individuation of the low‐similarity HMW‐MAA781–789RATVWMLRL peptide fragment as an immunodominant B‐cell epitope. Linear B‐cell determinant individuation was experimentally validated by dot blot immunoassay and NMR spectroscopy analysis. Regulation of physiologic self‐reactivity by the non‐self‐discrimination principle is discussed.Keywords
This publication has 34 references indexed in Scilit:
- Survival probabilities and hazard functions of malignant melanoma in Germany 1972–1996, an analysis of 10 433 patients. Evolution of gender differences and malignancyEuropean Journal of Cancer, 2002
- CUTANEOUS MELANOMA IN CHILDHOOD AND ADOLESCENCEPediatric Hematology and Oncology, 2002
- Antigenicity and Immunogenicity of Synthetic PeptidesBiologicals, 2001
- Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.Proceedings of the National Academy of Sciences, 1996
- Tolerance, Danger, and the Extended FamilyAnnual Review of Immunology, 1994
- Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanomaPharmacology & Therapeutics, 1993
- Active Specific Immunotherapy of Malignant Melanoma with Anti‐idiotypic Monoclonal AntibodiesThe Journal of Dermatology, 1993
- Epitope Selection and Design of Synthetic Vaccines Molecular Approaches to Enhancing Immunogenicity and Cross-Reactivity of Engineered VaccinesAnnals of the New York Academy of Sciences, 1993
- Melanoma Antigens: Immunological and Biological Characterization and Clinical SignificanceAnnual Review of Immunology, 1988
- Distribution and molecular characterization of a cell‐surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodiesInternational Journal of Cancer, 1981